PHARMA · GMI
Discovery Synthesis · The Core Story
NovaHelix Pharma · EMEA Generics · +500 bps GM on $1,400M Net Sales
Delta
465 bps
155 bps
spread — same data, same $1,400M mandate
0 of 5 teams opened R1 with a mix lens
firm-level signal
NovaHelix has $1,400M in EMEA generics net sales and a mandate to improve gross margin by 500 bps in three years — no new launches, no M&A, no headcount cuts. The only lever is mix and operational discipline. Five cross-functional teams ran the same simulation. Delta scored 465 bps. Alpha and Epsilon scored 310–320 bps. The 155 bps spread came from the same dataset, same mandate, and same constraints. Every team hit the same three traps in the same order: cost-first analysis in R1, fairness spread in R2, and mix discipline collapse under pressure in R3.
01
Open with mix, not cost
Start every GM review with: what is our product mix doing to gross margin? Not: where can we cut cost? The first question determines the allocation logic. No team in the simulation opened with mix — all five opened with cost.
02
Name the volume-vs-mix tension before R3
Commercial teams are rewarded for volume. Finance teams track mix. The tension between them destroyed 40 bps of potential margin in R3. No team named it before it materialised. Name it in the pre-read and the conversation changes.
03
Codify one mix-protection rule before the next planning cycle
Teams that held mix discipline under volume pressure landed 465 bps. Those that reverted landed 310–320 bps. The rule is simple: a volume deal that dilutes mix below threshold requires a named sign-off. Write it now.
PHARMA · GMI
Overall Combined · All 5 Teams
155 bps spread — same data, same $1,400M mandate
Delta
465 bps
310–320 bps
Alpha & Epsilon range
155 bps
spread — same data, same $1,400M mandate
0 of 5
0 of 5 teams opened R1 with a mix lens
TeamIdentityScoreBucket D EndKey Pattern
AlphaCountry-First310 bps14%+Fairness spread + shock reversion
BetaPortfolio-First12–13%12%Elegant theory, poor country execution
GammaSales-First11%15%Over-weighted field force, cut medical
DeltaEfficiency-First465 bps10%Across-the-board cuts early — recovered
EpsilonOne GMI320 bps11%Right language, avoided hard calls on mix
Delta performed best. Alpha and Epsilon scored at the bottom. The 155 bps spread came from the same dataset, same mandate, and same constraints. Every team hit the same three traps in the same order.
The simulation selects for a dominant behaviour pattern regardless of team composition. Delta's advantage was not superior skill — it was an identity least attached to the default first instinct. The system design produced the spread.
The offsite design is the intervention. Change the opening frame for the next session. The spread narrows when the first question changes — not when team composition changes.
PHARMA · GMI
Team Arc · Alpha
Score: 310 bps · Target: 500 bps · +40 bps mix opportunity — in the data, never opened
310 bps
Alpha final score (target: 500 bps)
+40 bps mix opportunity
+40 bps mix opportunity — in the data, never opened
3 of 8 dossiers
3 of 8 dossiers — all cost-side in R1
R1–R4
Same trap pattern every round — process unchanged
R1
Cost-first opening
3/8 dossiers
all cost-side
R2
Fairness spread
Confidence 52/100
0/3 growth picks
R3
Mix collapse under pressure
2 tensions
not codified
R4
Board case
310 bps
vs 500 target
Alpha opened with cost analytics (3 of 8 dossiers, all cost-side), spread resources fairly in R2, saw mix collapse under volume pressure in R3 with 2 concerns raised and neither recorded, and delivered 310 bps against a 500 bps Board target.
Alpha had the right language but the wrong reflexes. They could describe the mix opportunity — they could not defend it when commercial pressure hit. Two concerns dropped in session and never recorded is the diagnostic signal.
One fix: make the mix opportunity the first number in every session, not the last. Change the pre-read format. If +40 bps sits in the data and no one opens it, the framing is wrong.
PHARMA · GMI
Round 1 · System
How does the process perform under real time pressure and information constraints?
70%
Alpha analysis tokens on country deep-dives
$108M
SG&A locked in negative-margin franchises
+40 bps
Mix opportunity in data — never opened by any team
0 of 5
Teams started with a mix lens
All five teams spent Round 1 analysing cost-side data. No team opened with a mix view. Team Alpha opened 3 of 8 dossiers — all on cost. The +40 bps mix opportunity was visible in the product data from minute one and was never accessed.
When the first instinct is cost, the mix opportunity stays hidden. The system makes cost data easy to access and politically safe to discuss. Mix analysis requires a cross-portfolio view that exposes strategic choices — the format of the review determines what gets analysed.
Before the next GM review, restructure the opening pack: mix view first, cost data second. Require the first 15 minutes to answer: what is our product mix doing to gross margin? Owner: Head of Commercial Finance.
TEAM POLL
In your last GM or portfolio review, what data opened the session?
Arena's view: 71% of leadership teams open with cost data. The format of the first slide determines the first 30 minutes of conversation. Mix almost always appears second — which means it almost never drives the first decision.
PHARMA · GMI
Round 2 · People
How do leaders actually decide under governance and conviction pressure?
52/100
Alpha confidence score (stated: high)
2 of 2
Concerns dropped in session — neither recorded
0 of 3
Governance picks improving GM performance
0 of 5
Teams named the volume-vs-mix conflict before R3
In Round 2, Team Alpha reported high confidence at 52/100. They chose risk-mitigation governance in all three picks — none improved GM performance. Two material concerns were raised verbally and dropped. Neither was recorded.
High stated confidence and risk-averse decisions is the scar-tissue pattern. The system rewards keeping all products alive — not making hard mix choices. The two unrecorded concerns show the team's real risk perception exceeds their stated confidence.
Add a mandatory concerns log to all GM review sessions. Any concern raised verbally must be logged with a named owner and review date, or explicitly closed with a reason. Owner: GM Programme Lead.
INFERENCE CHECK
Alpha's confidence was stated as 'high' but Arena measured 52/100. What most accurately explains the gap?
PHARMA · GMI
Round 3 · System × People
What happens when shocks and pressure interact with the system and people inside it?
155 bps
Spread between best and worst team — same data
3 shocks
Volume pressure, pricing tension, supply risk
40 bps
GM uplift lost to volume-over-mix decisions
0 of 5
Teams had a pre-agreed mix-protection rule
Round 3 introduced three shocks: volume pressure from commercial, a pricing tension that diluted mix, and a supply expiry risk surfaced in R1 minute 9 that was never recorded. Three of five teams reverted to volume-first decisions under pressure. No team had a pre-agreed mix-protection rule.
Under pressure, systems revert to what teams are incentivised for. Commercial teams are rewarded for volume — mix discipline requires overriding that instinct in real time. Without a pre-agreed rule, the volume incentive wins every time.
Before the next planning cycle, write one rule: a volume deal that moves product mix below the agreed threshold requires a named sign-off before commitment. Test it in a 30-minute scenario session.
DECISION STAMP
Thinking about your own organisation: when a commercial shock hits (volume miss, pricing pressure), what most commonly happens to the strategic allocation decisions made in the planning cycle?
🔒 Stamped. Your response has been recorded.
Arena's view: In the simulation, 3 of 5 teams reverted to country-first or volume-first decisions under pressure — despite having articulated a different strategy. The pattern is structural, not individual. A pre-agreed trigger rule is the mechanism that converts instinct into discipline.